Anti-IL-36R antibodies, potentially useful for the treatment of psoriasis: a patent evaluation of WO2013074569

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.24, Iss.4, 2014-04, pp. : 477-479

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Antagonists of IL-1R: a patent evaluation (WO2012122985)

By Sette Claudio

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 911-914

Informa Healthcare

Access to resources Recommend Favorite

Clostridium difficile antibodies: a patent evaluation (WO2013028810)

By Lo Vecchio Andrea Della Ventura Bartolomeo Nicastro Emanuele

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1635-1640

Informa Healthcare

Access to resources Recommend Favorite

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178

By Nakajima Katsuyuki Kobayashi Junji

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. : 113-119

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of WO2013076170: the use of a dihydroorotate dehydrogenase inhibitor for the treatment of psoriasis

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1391-1394

Informa Healthcare

Access to resources Recommend Favorite

Casein hydrolysate for uterine infection treatment: a patent evaluation (WO2011132191)

By Cozza Giorgio

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 575-578

Informa Healthcare

Access to resources Recommend Favorite